In yet a third judicial ruling, The U.S. District Court of Appeals for the District of Columbia upheld a rule by the Trump Administration that hospitals will have to publicly disclose the prices they negotiate with insurance companies.
While the other two rulings went against the Trump Administration, this one was a win on a key piece of Trump’s health-care agenda at the end of his administration.
Under the hospital price transparency rule, some 6,000 U.S. hospitals will have to publicly provide their negotiated rates with insurers for 300 common medical services, along with the discounted cash price they’re willing to accept for those procedures.
Industry groups and health systems led by the American Hospital Association challenged the rule, arguing that the rule would do more harm than good because it won’t “tell consumers their actual out-of-pocket costs, will likely produce confusion and may be less effective than the price-transparency tools the hospital field has been developing.”
